US Patent:
20130184251, Jul 18, 2013
Inventors:
Janssen Pharmaceutica, NV - Beerse, BE
Jose Clemente - West Chester PA, US
Scott L. Dax - Landenberg PA, US
Chris Flores - Spring House PA, US
Li Liu - Doylestown PA, US
Mark J. Macielag - Spring House PA, US
Mark McDonnell - Lansdale PA, US
Marina Nelen - Spring House, RU
Erica Nulton - Spring House PA, US
Stephen Prouty - Philadelphia PA, US
Matthew Todd - Spring House PA, US
Sui-Po Zhang - Radnor PA, US
Bin Zhu - Spring House PA, US
Assignee:
Janssen Pharmaceutica, NV - Beerse
International Classification:
C07D 403/12
C07D 401/14
C07D 405/14
C07D 401/12
C07D 413/14
C07D 409/14
C07D 403/14
C07D 417/12
US Classification:
51421018, 544295, 540598, 544364, 544363, 544367, 544369
Abstract:
Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the inhibition of MGL, including pain. Such compounds are represented by Formula (I) as follows: